Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 27Neoplasm Metastasis 8Colonic Neoplasms 7Rectal Neoplasms 5Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasms 3Carcinoma, Neuroendocrine 2Pancreatic Adenocarcinoma Metastatic 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Colorectal Adenocarcinoma 1Margins of Excision 1Liver Metastasis Colon Cancer 1Gastroesophageal Adenocarcinoma 1CRC 1Advanced Gastric or EGJ Cancer 1Adenocarcinoma 1

Interventions

Nivolumab 2pembrolizumab 1folfirinox 1durvalumab 1Trastuzumab 1Single Person 1Paclitaxel 1Irinotecan 1IFL protocol 1Folfox protocol 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastroesophageal Adenocarcinoma × IFL protocol × Clear all
NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡